• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pfizer's vaccine raises allergy concerns.

作者信息

de Vrieze Jop

机构信息

Jop de Vrieze is a science journalist in Amsterdam.

出版信息

Science. 2021 Jan 1;371(6524):10-11. doi: 10.1126/science.371.6524.10.

DOI:10.1126/science.371.6524.10
PMID:33384356
Abstract
摘要

相似文献

1
Pfizer's vaccine raises allergy concerns.辉瑞公司的疫苗引发了人们对过敏的担忧。
Science. 2021 Jan 1;371(6524):10-11. doi: 10.1126/science.371.6524.10.
2
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.基于脂质纳米颗粒的新冠疫苗的过敏反应和过敏症
Mol Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5.
3
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
4
Nucleoside-modified messenger RNA COVID-19 vaccine platform.核苷修饰的信使 RNA COVID-19 疫苗平台。
J Med Virol. 2021 Jul;93(7):4054-4057. doi: 10.1002/jmv.26924. Epub 2021 Mar 25.
5
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.对 COVID-19 mRNA 疫苗过敏反应的潜在机制。
J Allergy Clin Immunol. 2021 Jun;147(6):2075-2082.e2. doi: 10.1016/j.jaci.2021.04.002. Epub 2021 Apr 20.
6
Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.对 PEG 过敏的患者中，对 BNT162b2 的嗜碱性粒细胞反应是由聚乙二醇化脂质纳米颗粒介导的。
J Allergy Clin Immunol. 2021 Jul;148(1):91-95. doi: 10.1016/j.jaci.2021.04.032. Epub 2021 May 12.
7
Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?对第一剂新冠疫苗过敏：聚乙二醇（PEG）是罪魁祸首吗？
Br J Anaesth. 2021 Mar;126(3):e106-e108. doi: 10.1016/j.bja.2020.12.020. Epub 2020 Dec 17.
8
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.mRNA新冠疫苗在患有皮肤和全身性肥大细胞增多症且伴有肥大细胞活化症状和过敏反应的患者中耐受性良好。
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
9
Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: Does urgency meet major safety criteria?意大利 COVID-19 时代疫苗犹豫和 mRNA 疫苗“神话”：紧迫性符合主要安全性标准吗？
J Med Virol. 2021 Jul;93(7):4049-4053. doi: 10.1002/jmv.26922. Epub 2021 Mar 25.
10
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.

引用本文的文献

1
Isomerization of Poly(ethylene glycol): A Strategy for the Evasion of Anti-PEG Antibody Recognition.聚乙二醇的异构化：一种逃避抗聚乙二醇抗体识别的策略。
J Am Chem Soc. 2025 Jun 25;147(25):21538-21548. doi: 10.1021/jacs.5c02716. Epub 2025 Jun 13.
2
Better the devil you know than the devil you don't - PEG challenges in nanomedicine.明枪易躲，暗箭难防——纳米医学中的聚乙二醇挑战。
Nat Nanotechnol. 2025 May;20(5):580-583. doi: 10.1038/s41565-025-01925-0.
3
Nucleic acid functionalized extracellular vesicles as promising therapeutic systems for nanomedicine.
核酸功能化细胞外囊泡作为纳米医学中颇具前景的治疗系统。
Extracell Vesicles Circ Nucl Acids. 2022 Feb 22;3(1):14-30. doi: 10.20517/evcna.2021.21. eCollection 2022.
4
Knowledge, Beliefs, and Intention to Vaccinate against COVID-19 among the Seventh Day Adventists in Southeast Asia Region.东南亚地区基督复临安息日会信徒对新冠疫苗的认知、信念及接种意愿
Acta Med Philipp. 2023 Jun 28;57(6):18-23. doi: 10.47895/amp.vi0.4549. eCollection 2023.
5
Striving for Uniformity: A Review on Advances and Challenges To Achieve Uniform Polyethylene Glycol.追求一致性：关于实现均匀聚乙二醇的进展与挑战的综述
Org Process Res Dev. 2024 Apr 1;28(4):860-890. doi: 10.1021/acs.oprd.3c00428. eCollection 2024 Apr 19.
6
Short-term side effects of BNT162b2 vaccine in primary care settings in Qatar: a retrospective study.卡塔尔基层医疗环境中BNT162b2疫苗的短期副作用：一项回顾性研究。
Front Public Health. 2024 Apr 10;12:1384327. doi: 10.3389/fpubh.2024.1384327. eCollection 2024.
7
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress.TP53 在肿瘤微环境中介导免疫逃逸：研究进展概述。
Mol Biol Rep. 2024 Jan 25;51(1):205. doi: 10.1007/s11033-023-09097-7.
8
Nanoparticles and Antiviral Vaccines.纳米颗粒与抗病毒疫苗
Vaccines (Basel). 2023 Dec 27;12(1):30. doi: 10.3390/vaccines12010030.
9
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.新型冠状病毒肺炎（COVID-19）：严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）变异株概述——当前疫苗和药物研发进展。
Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023.
10
Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds.向具有不同过敏背景的受试者接种BNT162b2 mRNA新冠疫苗。
Front Immunol. 2023 Aug 15;14:1172896. doi: 10.3389/fimmu.2023.1172896. eCollection 2023.